Wockhardt soared 13.64% to Rs 780 after the company’s experimental antibiotic, Zaynich, successfully treated a US cancer patient with a chronic thigh infection caused by extremely resistant bacteria.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
